Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2002 5
2003 2
2004 5
2005 4
2006 4
2007 8
2008 7
2009 8
2010 11
2011 10
2012 7
2013 9
2014 5
2015 11
2016 6
2017 6
2018 6
2019 8
2020 9
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Results by year
Filters applied: . Clear all
Page 1
Natural killer cell immunotypes related to COVID-19 disease severity.
Maucourant C, Filipovic I, Ponzetta A, Aleman S, Cornillet M, Hertwig L, Strunz B, Lentini A, Reinius B, Brownlie D, Cuapio A, Ask EH, Hull RM, Haroun-Izquierdo A, Schaffer M, Klingström J, Folkesson E, Buggert M, Sandberg JK, Eriksson LI, Rooyackers O, Ljunggren HG, Malmberg KJ, Michaëlsson J, Marquardt N, Hammer Q, Strålin K, Björkström NK; Karolinska COVID-19 Study Group. Maucourant C, et al. Among authors: malmberg kj. Sci Immunol. 2020 Aug 21;5(50):eabd6832. doi: 10.1126/sciimmunol.abd6832. Sci Immunol. 2020. PMID: 32826343 Free PMC article.
Deciphering Natural Killer Cell Homeostasis.
Pfefferle A, Jacobs B, Haroun-Izquierdo A, Kveberg L, Sohlberg E, Malmberg KJ. Pfefferle A, et al. Among authors: malmberg kj. Front Immunol. 2020 May 12;11:812. doi: 10.3389/fimmu.2020.00812. eCollection 2020. Front Immunol. 2020. PMID: 32477340 Free PMC article. Review.
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.
Wagner JA, Rosario M, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, Sullivan RP, Jewell BA, Becker-Hapak M, Schappe T, Abdel-Latif S, Ireland AR, Jaishankar D, King JA, Vij R, Clement D, Goodridge J, Malmberg KJ, Wong HC, Fehniger TA. Wagner JA, et al. Among authors: malmberg kj. J Clin Invest. 2017 Nov 1;127(11):4042-4058. doi: 10.1172/JCI90387. Epub 2017 Oct 3. J Clin Invest. 2017. PMID: 28972539 Free PMC article.
Natural killer cell-mediated immunosurveillance of human cancer.
Malmberg KJ, Carlsten M, Björklund A, Sohlberg E, Bryceson YT, Ljunggren HG. Malmberg KJ, et al. Semin Immunol. 2017 Jun;31:20-29. doi: 10.1016/j.smim.2017.08.002. Epub 2017 Sep 6. Semin Immunol. 2017. PMID: 28888619 Review.
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML.
Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ. Björklund AT, et al. Among authors: malmberg kj. Clin Cancer Res. 2018 Apr 15;24(8):1834-1844. doi: 10.1158/1078-0432.CCR-17-3196. Epub 2018 Feb 14. Clin Cancer Res. 2018. PMID: 29444931 Free article. Clinical Trial.
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.
Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg KJ, Ljunggren HG, Miller JS, Bryceson YT. Schlums H, et al. Among authors: malmberg kj. Immunity. 2015 Mar 17;42(3):443-56. doi: 10.1016/j.immuni.2015.02.008. Immunity. 2015. PMID: 25786176 Free PMC article.
Prospects for NK Cell Therapy of Sarcoma.
Lachota M, Vincenti M, Winiarska M, Boye K, Zagożdżon R, Malmberg KJ. Lachota M, et al. Among authors: malmberg kj. Cancers (Basel). 2020 Dec 11;12(12):3719. doi: 10.3390/cancers12123719. Cancers (Basel). 2020. PMID: 33322371 Free PMC article. Review.
120 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page